Grace Therapeutics (GRCE)
NASDAQ:GRCE
Holding GRCE?
Track your performance easily

Grace Therapeutics (GRCE) Stock Investors

1,140 Followers
Based on 766,394 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GRCE
On average, investors allocate 0.00% of their portfolios to GRCE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 766,394 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GRCE

18.6%
Last 7
Days
30.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GRCE, out of 766,394 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GRCE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,658 investors who made their portfolios public
The table shows changes in GRCE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GRCE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
5.22%
-0.88%
+0.22%
1.81B
Industrials
DraftKings
5.42%
+0.81%
+0.53%
35.26B
Consumer Cyclical
Nio
9.78%
-0.13%
+0.73%
11.09B
Consumer Cyclical
Carnival
6.50%
+1.32%
+9.30%
30.17B
Consumer Cyclical
Lucid Group
5.82%
+0.12%
+1.65%
6.66B
Consumer Cyclical
XPeng, Inc. ADR
5.58%
-0.35%
-0.79%
13.95B
Consumer Cyclical
Viking Therapeutics
4.94%
+0.51%
+5.42%
7.63B
Healthcare
Riot Platforms
5.30%
+0.93%
+2.57%
4.26B
Financial
Marathon Digital Holdings
5.75%
+1.71%
+1.98%
5.67B
Financial
GE Aerospace
4.94%
+1.61%
+7.60%
200.02B
Industrials
Based on the activity of 766,394 active portfolios
Open your Smart Portfolio

GRCE Investor Analysis

GRCE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.9%
of GRCE holders
are under 35
Average Segment Performance
Average P/E Ratio26.57
Beta9.43
Dividend Yield51.54%
GRCE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.5%
of GRCE holders
are between 35–55
Average Segment Performance
Average P/E Ratio24.84
Beta18.28
Dividend Yield25.17%
GRCE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
24.6%
of GRCE holders
are over 55
Average Segment Performance
Average P/E Ratio23.97
Beta8.44
Dividend Yield41.02%
Overview of age group and performance of GRCE stock investors
See who invests in GRCE according to age group and performance.

FAQ

How many retail Investors hold GRCE?
<0.1% of TipRanks' retail investors hold GRCE in their portfolios.
    What is GRCE Investor Sentiment?
    GRCE’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GRCE in the last 7 days?
      ▲ 18.6% of TipRanks' retail investors changed their holding of GRCE in the last 7 days.
        What percentage of retail investors changed their holding of GRCE in the last 30 days?
        ▲ 30.1% of TipRanks' retail investors changed their holding of GRCE in the last 30 days.
          What is the average age of retail investors who hold GRCE?
          The average age of GRCE Holders is between 35–55.
            What other stocks have GRCE investors also bought?
            GRCE Investors also bought PLUG, DKNG, NIO, CCL, LCID, XPEV, VKTX, RIOT, MARA, GE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis